Intelligent Bio Solutions (INBS) EPS (Basic) (QoQ) (2020 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Intelligent Bio Solutions | 13.61 Mn | 12.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 415.65% |
| Mar 31, 2025 | 11.09% |
| Dec 31, 2024 | -608.57% |
| Sep 30, 2024 | -369.23% |
| Jun 30, 2024 | 118.18% |
| Mar 31, 2024 | 30.92% |
| Dec 31, 2023 | 83.41% |
| Sep 30, 2023 | 45.64% |
| Jun 30, 2023 | 66.56% |
| Mar 31, 2023 | -1,135.07% |
| Dec 31, 2022 | -243.21% |
| Sep 30, 2022 | 41.94% |
| Jun 30, 2022 | -55.87% |
| Mar 31, 2022 | 61.51% |
| Dec 31, 2021 | -4,550.00% |
| Sep 30, 2021 | 99.22% |
| Jun 30, 2021 | -4,666.67% |
| Mar 31, 2021 | -17.39% |
| Dec 31, 2020 | -91.67% |
| Sep 30, 2020 | -140.00% |
| Jun 30, 2020 | -400.00% |
| Mar 31, 2020 | 95.45% |